Efficacy of AirGLovE in Difficult Venous Access (NCT05127668) | Clinical Trial Compass
CompletedNot Applicable
Efficacy of AirGLovE in Difficult Venous Access
United Kingdom34 participantsStarted 2019-03-29
Plain-language summary
To determine whether Airgloveā¢ warming device dilates upper limb veins to the same degree as the warm water immersion (WWI) method.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants \> 18 years old
* Able to give written informed consent
* Able to understand and complete questionnaire forms independently
Exclusion Criteria:
* Participants \< 18 years old
* Participants with cancer and/or undergoing chemotherapy
* Participants with difficult to cannulate veins (DTCV)
* Participants with lymphoedema in either hand
* Participants with pre-existing Raynaud's disease
* Participants with Diabetes (Type 1 \& 2)
* Participants with generalised anxiety disorder
* Participants with diagnosis of hypertension
* Participants with any cardiovascular disease, previous stroke, episodes of DVT, recent treatment for venous thromboembolism (VTE), recently administered heparin, participants on warfarin or any anticoagulant treatment (including NOACs).
* Participants not able to give written informed consent
* Participants not able to comprehend or complete questionnaire forms independently
What they're measuring
1
Name of Measurement: Change in measurement of vein diameter by ultrasound
Timeframe: Change from baseline measurements taken within 2 minutes of the intervention